There's still time to apply for this great opportunity - please share with your networks!

EACR - European Association for Cancer Research@helloeacr.bsky.social · 2w ago

EACR-@themarkfdn Postdoctoral Fellowships are awarded for a period of three years and support excellent postdoctoral researchers in laboratories throughout Europe. Is that you? 👀 Apply by 19 August: eacr.org/eacr-fellows...

“I feel confident that we’ll uncover ways to treat cachexia that will make it more reversible. Ideally, we'll prevent it."—Mark Foundation CEO Ryan Schoenfeld Great feature in @nature.com on the insights changing our understanding of cancer’s deadly co-conspirator. www.nature.com/articles/d41...

New hope in the fight against cachexia — cancer’s deadly co-conspirator

Scientists are getting closer to understanding the wasting and fatigue that often accompanies cancer. Treatments could be on the horizon.

nature.com

So glad you enjoyed it!

Alberto Hernández Barranco@ahernandezb.bsky.social · 2mo ago

So grateful for the support of the @helloeacr.bsky.social and the Mark Foundation Postdoctoral Fellowships to attend the amazing 2026 annual EACR conference 🧪🧫 in Budapest with the @joycelab.bsky.social Already looking forward to the 2027 edition in Bilbao🇪🇸 !

EACR-Mark Foundation for Cancer Research Postdoctoral Fellowships are awarded for a period of three years and support excellent postdoctoral researchers in laboratories throughout Europe. Is that you? 👀 Apply by 19 August: eacr.org/eacr-fellows...

Julie Marie Mazet delivers the EACR - @themarkfdn.bsky.social Postdoctoral Fellowship Award Lecture on unlocking CD8+ T cell anti-tumour activity in brain metastasis at #EACR2026

Very happy to present my work at #EACR2026, made possible through the support of EACR- @themarkfdn.bsky.social Postdoctoral Fellowship 😊 #womeninSTEM

EACR - European Association for Cancer Research@helloeacr.bsky.social · 2mo ago

Martha Zarou delivers the EACR - @themarkfdn.bsky.social Postdoctoral Fellowship Award Lecture 'A role for mitochondrial one carbon metabolism in early pancreatic cancer development' #EACR2026

It was a pleasure to present my research at #EACR2026, supported by @helloeacr.bsky.social @themarkfdn.bsky.social postdoctoral fellowship. Thank you to all organizers & participants!

EACR - European Association for Cancer Research@helloeacr.bsky.social · 2mo ago

Christina Metoikidou delivers the EACR - @themarkfdn.bsky.social Postdoctoral Fellowship Award Lecture on dissecting tissue-resident and circulating trajectories to CD8 T cell dysfunction in the tumour microenvironment at #EACR2026

Clinical trial results don’t usually get standing ovations—but Brian Wolpin and his team truly deserved their reception at #ASCO26. Seeing Phase 3 data on the impact of daraxonrasib in patients with advanced pancreatic cancer sent chills through the entire room. 🧵 www.theguardian.com/society/2026...

Daily pill can double survival time for world’s deadliest cancer, trial shows

Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer

theguardian.com

Great feature on Drug Discovery Award winner @corsello.bsky.social by @stanforddeptmed.bsky.social! Corsello and his collaborator, Nathanael Gray, are developing novel molecular glue degraders for #pancreaticcancer. medicine.stanford.edu/news/stories...

Teaching Pancreatic Cancer Cells to Self-Destruct

Q&A with Steven Corsello, MD, on a new approach to treating pancreatic cancer.

medicine.stanford.edu

Exciting new work from Professor Chris Garcia, co-investigator on MATCHMAKERS 👏 Team MATCHMAKERS is funded through Cancer Grand Challenges by @cancerresearchuk.org, the National Cancer Institute and @themarkfdn.bsky.social

Deep peptide recognition profiling decodes TCR specificity and enables disease-associated antigen discovery - Nature Biotechnology | Cancer Grand Challenges

Exciting new work from K. Christopher Garcia, co-investigator on MATCHMAKERS 👏   The study published in Nature Biotechnology shows that deep peptide-recognition profiling, combined with machine learni...

linkedin.com

When do cells shift from benign to malignant? In @cellcellpress.bsky.social, Endeavor Awardees Scott Lowe, @danapeer.bsky.social, and Paul Romesser use spatial mapping to identify a "progenitor" state that could be targeted for early interception of pancreatic cancer. www.cell.com/cell/fulltex...

Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition

Opposing oncogenic and tumor-suppressive forces establish a progenitor-like state that builds a self-reinforcing niche to drive benign-to-malignant transition in pancreatic cancer models. Disruption o...

cell.com

1 in 100 women in the US will be diagnosed with ovarian cancer in their lifetime. For more than half, that diagnosis will come once the disease has already spread, when treatment options are limited. Two of our recent grants aim to change that reality. #WorldOvarianCancerDay.

📢 Funding opportunity: $500,000 grants for aging & cancer research!📢 With the Waxman Institute, @theaacr.bsky.social @bloodcancerunited.bsky.social, @bloodcanceruk.bsky.social & the Mike and Sofia Segal Foundation, we are seeking proposals that examine the fundamental role of aging in cancer.

How does lung cancer actually spread? In @Nature, ASPIRE Awardee @charlesswanton.bsky.social sequenced 501 tumor samples to trace how cancer advances from diagnosis to death. One key finding: >50% of metastases were seeded by other metastases.  www.nature.com/articles/s41...

Evolutionary characterization of lung cancer metastasis - Nature

DNA-sequencing data from primary tumours and paired metastases from participants in the TRACERx lung study and PEACE autopsy programme are used to analyse the metastatic diversity of advanced non-smal...

nature.com

Are you in years 3-8 of an independent faculty position? The Emerging Leader Award was built to give you the research runway you need. The award now offers $1M over 4 years and is open to investigators worldwide!🌎 Apply by April 30: themarkfoundation.org/emerging-lea... #ResearchFunding

Emerging Leader Award | The Mark Foundation for Cancer Research

themarkfoundation.org

We're proud that over 60 members of the Mark Foundation community are presenting or chairing sessions at #AACR26! Headed to San Diego? We've made a list of their talks to help you plan your weekend: themarkfoundation.org/blog/mark-fo...

Mark Foundation Grantees at AACR 2026: Highlighting Research Advancements | The Mark Foundation for Cancer Research

Each year, the American Association for Cancer Research (AACR) convenes researchers at the leading edge of oncology at its Annual Meeting. This year, the Mark Foundation for Cancer Research is proud…

themarkfoundation.org

Do you know an early-career scientist pushing the boundaries of cancer research?🧬 Our Emerging Leader Award offers $1M in #researchfunding to investigators worldwide. Tag a colleague or share this post to help us spread the word! LOI deadline is April 30.

Emerging Leader Award | The Mark Foundation for Cancer Research

themarkfoundation.org

Did you catch our news during #MarkSymposium? We’re accepting applications for our 2026 Emerging Leader Awards, now offering $1 million over 4 years & open to investigators worldwide! Submit your LOI by April 30: themarkfoundation.org/emerging-lea... #ResearchFunding

Emerging Leader Award | The Mark Foundation for Cancer Research

themarkfoundation.org

Immune surveillance can be a double-edged sword. ⚔️ In @nature.com, Endeavor Awardee Tobias Janowitz shows that the same B cell response targeting NMDAR-expressing breast cancer tumors can mature into antibodies that trigger autoimmune disease. www.nature.com/articles/s41...

Ectopic NMDAR expression in cancer unmasks germline-encoded autoimmunity - Nature

NMDAR expression is sufficient to induce B cell recruitment and affinity maturation, resulting in receptor-modulating antibodies that connect anti-cancer immunity and autoimmunity.

nature.com

Our final talks at #MarkSymposium 2026 focused on cancer immunology, with deep dives into autoantibodies by @aaronmring.bsky.social and T cell exhaustion by @ejohnwherry.bsky.social.

Can diet be a drug? 🥦 Jennifer McQuade and Semir Beyaz explored the link between nutrition and cancer therapy response, with insights on how lipids, fiber, & the microbiome shape immune responses. #MarkSymposium

📢We have exciting news to share on Day 2 of #MarkSymposium: Applications for this year’s Emerging Leader Awards are now open! These early career awards are now $1 million, and researchers anywhere in the world are eligible. Learn more: themarkfoundation.org/2026/03/the-...

The Mark Foundation for Cancer Research Announces Global Expansion and $1M Funding Boost for Flagship Emerging Leader Award | The Mark Foundation for Cancer Research

NEW YORK, NY – March 25, 2026 – The Mark Foundation for Cancer Research today announced a major evolution of its flagship Emerging Leader Award (ELA) program, significantly increasing its financial…

themarkfoundation.org

We're back with Day 2 of #MarkSymposium! Our first session, on novel cancer therapies, featured a powerhouse lineup including William Sellers, @amanglik.bsky.social, and @juliensage.bsky.social. The future of targeted treatment is bright. ⚡️ #CancerTherapy

Last night, we honored the legendary Samuel Waxman, MD, for his remarkable scientific career & leadership as the founder of the Samuel Waxman Cancer Research Foundation. Cheers to the future of the Waxman Institute for Aging & Cancer, now officially a branch of The Mark Foundation! #MarkSymposium

Our second session of the day focused on Cancer Across the Lifespan, with excellent talks on the intersection of aging & cancer by @naxerova.bsky.social, Scott Lowe, and Kornelia Polyak. 🧬 #MarkSymposium

🏆This year, we’re thrilled to have Nobel Laureate William Kaelin Jr., MD, delivering our keynote address. Incredible to get insights on the frontiers of research from a true leader in the field! #MarkSymposium

And now, the 2026 #MarkSymposium has officially begun! Our first session is a deep dive into brain tumors.🧠 Grateful to hear from Peter Sorger, Mario Suva, & Dimitrios Mathios on how spatial analysis and liquid biopsies are changing the game for #glioblastoma detection and treatment. #MarkSymposium

Happening now - our inaugural Emerging Leader Award Summit!🌟 In addition to sharing updates on their work, our ELA awardees are discussing the pressing challenges faced by early-career researchers & how foundations like The Mark Foundation can support them. #MarkSymposium

Last night, current and past Mark Foundation Emerging Leader Award (ELA) winners gathered with this year’s recipients (@jborniger.bsky.social, Christine Chio, @lucas.farnunglab.com, Mariella Filbin & Christopher Johnston) to celebrate eight years of this transformational program. #MarkSymposium

The 2026 Mark Foundation Scientific Symposium officially kicks off tomorrow!🧬 We’re hosting over 200 scientists from around the globe to hear & discuss the latest breakthroughs in cancer research from our grantees. Stay tuned for live updates! #MarkSymposium #CancerResearch